Taevas
ThailandPersonal Care & Beauty
Product Registration
Market Access for Product-Registration in Thailand
Navigating the complexities of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to optimize market entry, accelerate patient access, and maximize the commercial potential of your l
Market
Global
Industry
Product-Registration
Regulator
Diverse National Regulatory Bodies
Timeline
Initial Strategy: 4-6 weeks
Deliverables
Report, Roadmap, Strategy
What We Deliver
6 Pillars of Market Access
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Regulatory Landscape Analysis
Thorough assessment of country-specific regulatory requirements, submission pathways, and approval criteria to identify optimal registration strategies and potential hurdles.
Global regulatory intelligence
Gap analysis and risk assessment
How It Works
How It Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1
Initial Consultation & Strategic Alignment
We begin with an in-depth consultation to understand your product, target markets, and strategic objectives. This phase establishes the scope and key performance indicators for your global market access journey.
Market Snapshot
Market Overview: Global + Product-Registration
Increasing Regulatory Divergence
The global landscape for product registration is characterized by increasingly divergent national and regional regulatory requirements, demanding sophisticated strategies for simultaneous or sequential market entry.
HTA & Payer Scrutiny
Health Technology Assessments (HTAs) and payer bodies are intensifying their scrutiny of product value, requiring robust evidence generation and compelling value propositions beyond clinical efficacy.
Importance of Early Engagement
Proactive engagement with regulatory bodies, payers, and key opinion leaders early in the development lifecycle is crucial for shaping market access pathways and mitigating potential barriers.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining recommended pathways, timelines, and resource allocation for successful product registration and market entry across target geographies.
Regulatory & HTA Pathway Roadmap
A detailed, country-specific roadmap identifying critical milestones, data requirements, and strategic approaches for navigating diverse regulatory and HTA submission processes.
Value Dossier Framework & Payer Communication Toolkit
Templates and guidance for developing compelling value dossiers and payer communication materials tailored to meet the specific evidence needs of global market access stakeholders.
Who This Is For
Use Cases
Orphan Drug
Orphan Drug Global Launch
A biotech firm developed a novel orphan drug for a rare disease and needed to secure market access across North America, Europe, and select APAC countries simultaneously.
Outcome
Taevas facilitated expedited regulatory pathways and compelling HTA submissions, achieving successful multi-regional launch within 18 months.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform your product registration into a strategic market access success. Our expertise ensures your innovations reach patients efficiently and effectively worldwide.
Accelerate Time to Market
Optimize Reimbursement Potential
Mitigate Regulatory Risks
Maximize Commercial Success